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IndiaABSTRACT
Objective: To report the ﬁndings of inﬂuenza surveillance programme from Union
territory of Puducherry and to document the clinical and epidemiological data of inﬂuenza
viruses over a ﬁve year period from 2009 to 2013.
Methods: Respiratory samples were collected from patients with inﬂuenza-like illness
from 2009 to 2013 as part of routine diagnostic and surveillance activity. Detection of
pandemic inﬂuenza A (H1N1) 2009, inﬂuenza A (H3N2) and inﬂuenza B was done using
Real-time PCR.
Results: Of the total 2247 samples collected from patients with inﬂuenza-like illness
during the study period 287 (12.7%) and 92 (4.0%) were positive for inﬂuenza A (H1N1)
2009 and inﬂuenza A (H3N2) respectively. A subset of 557 of these samples were also
tested for inﬂuenza B and 24 (4.3%) were positive. Signiﬁcantly higher positivity rate for
both viruses was observed in adults when compared with children. The peak positivity of
inﬂuenza A (H1N1) 2009 was observed in 2009 followed by 2012, while that of inﬂuenza
A (H3N2) was more uniformly distributed with the exception of 2012. Overall mortality
rate due to inﬂuenza A (H1N1) 2009 was 7.6% while it was 1% for inﬂuenza A (H3N2).
Each year inﬂuenza-like illness and inﬂuenza virus activity coincided with period of high
rainfall and low temperature except in the ﬁrst half of 2012.
Conclusions: As the sole referral laboratory in this region, the data provides a
comprehensive picture of inﬂuenza activity. This information will be useful in future
planning of the vaccine schedule and inﬂuenza pandemic preparedness.1. Introduction
Inﬂuenza viruses have the potential to cause contagious
respiratory illness ranging from mild ﬂu to severe respiratory
illness resulting in death. In April 2009, a new inﬂuenza A virus
(H1N1) emerged abruptly and within a few weeks there was a
global spread of this virus leading to more than 4500 deaths by
October 2009 [1]. The ﬁrst case of pandemic inﬂuenza in India
was reported from Hyderabad in May 2009 [2], immediately
after which Inﬂuenza surveillance system was put in place
with the support of National Center for Disease Control, New
Delhi and World Health Organization. Twelve regional
laboratories were set up across India under Integrated Disease
Surveillance Project network with the aim to provideinformation regarding national and local inﬂuenza activity and
control efforts. As a part of this network, in July 2009,
Regional Inﬂuenza Laboratory was set up at Jawaharlal
Institute of Postgraduate Medical Education and Research
(JIPMER), Puducherry, to diagnose inﬂuenza infection in
patients referred from government and private hospitals in and
around Union territory of Puducherry. From November 2011,
this laboratory started sentinel surveillance activity with three
sentinel centers; two from Puducherry (JIPMER hospital and
Indira Gandhi Government General Hospital) and one from
Karaikal (Karaikal Government General Hospital). As the sole
referral laboratory from this part of the country, it gives a
nearly complete picture of inﬂuenza activity in this region. To
the best of our knowledge, there are no epidemiological
studies on inﬂuenza burden reported from this territory post-
inﬂuenza A (H1N1) 2009 pandemic. Hence, the aim of this
study was to report the ﬁndings of inﬂuenza virus surveillance
from Union territory of Puducherry, and to document the clinical
and epidemiological data of inﬂuenza viruses.cle under the CC BY-NC-ND
Figure 1. ILI surveillance ﬂowchart.
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2.1. Geographic details of Union territory of
Puducherry
The Union territory of Puducherry has a hot and humid
climate. It lies at latitude of 11460 to 12300 North and a
longitude of 79360 to 79520East in the Southern part of India.
The territory extends over an area of 479 Sq. km on the Coro-
mandel Coast of Bay of Bengal. Total population is 1 244464 as
per the 2011 census. The average maximum temperature is
31.5 C and average minimum temperature is 23.9 C. Summer
is from March through July and winter is from December
through February. The rainy months of this area are September
to December. Meteorological (temperature and rainfall) data of
Puducherry for the period between November 2011 and
December 2013 were obtained from the Regional Meteorolog-
ical Centre, Chennai [No. 8043/CS-(ER)-032 dated 30-07-
2014].
2.2. Routine inﬂuenza testing during pandemic and post-
pandemic periods
Clinical specimens including nasal/throat/nasopharyngeal
swabs/tracheal aspirates were collected by physicians from
patients with severe respiratory illness, admitted to govern-
ment and private hospitals in and around Puducherry and sent
to Regional Inﬂuenza laboratory at JIPMER in cold chain.
Immediate testing for inﬂuenza A (H1N1) 2009, inﬂuenza A
(H3N2) and inﬂuenza B virus identiﬁcation was done by
reverse transcriptase real-time polymerase chain reaction
according to Centers for Disease Control and Prevention
protocol [3].
2.3. Inﬂuenza-like illness (ILI) surveillance
Apart from routine inﬂuenza testing, according to the
guidelines of National Inﬂuenza-like illness surveillance pro-
gramme, nasopharyngeal samples were collected from patients
(both children and adults) with symptoms of ILI deﬁned as fever
(38 C) plus either cough or sore throat, attending the
outpatient care facilities in the 3 sentinel centers; JIPMER
hospital, Indira Gandhi Government General Hospital and
Karaikal Government General Hospital (Figure 1) In addition,
respiratory specimens were also collected from hospitalized
patients with severe acute respiratory illness (Figure 2) [4].
Patients with a history of acute respiratory infection in the
preceding 30 d were excluded. Patient information including
age, gender, clinical presentation, underlying conditions,
outcome, travel and treatment details were recorded using a
structured proforma.
2.4. Nucleotide sequencing and phylogenetic analysis
Sequencing of hemagglutinin (HA) gene and neuraminidase
(NA) gene was done for representative swine inﬂuenza A
(H1N1) 2009 isolates of each year using gene-speciﬁc forward
and reverse primers. The nucleotide sequence data from the
study isolates were deposited in National center for Biotech-
nology information-GenBank with the accession numbers
KM654292, KM654293, KM654294 and KM654295.2.5. Statistical methods
The proportions were presented in percentages wherever
applicable. The positivity rate across age groups, gender and
inpatient-outpatient details were compared by the Chi-square
test using Openepi software version 3.03. Statistical signiﬁcance
was concluded if the P-value was <0.05.
3. Results
3.1. ILI activity during 2009–2013
During the study period (May 2009–December 2013), res-
piratory samples were collected from 2247 patients with
symptoms of inﬂuenza-like illness. Among the total, 523 (23%),
429 (19%), 153 (7%), 717 (32%) and 425 (19%) samples were
collected in 2009, 2010, 2011, 2012 and 2013 respectively
(Table 1). Out of 2247 samples collected, 1314 (58%) were
from out patients and 933 (42%) were from patients who were
hospitalized with severe respiratory complications; 1691 (75%)
were adults (>13 years), 556 (25%) children (A: C ratio, 3:1); 1
104 (49%) were male and 1143 (51%) were female (M: F ratio,
1:1). Maximum numbers (52%) of patients were in the age
group of 20–49 years, followed by 5–19 years (19%), 0–4 years
(15%), 50–64 years (10%) and 65 years (4%). Major clinical
Table 2
Clinical conditions of ILI patients.
Clinical conditions n (%)
Clinical symptoms
Fever 2202 (98)
Cough 1909 (85)
Sore throat 1325 (59)
Dyspnea 944 (42)
Running nose 472 (21)
Myalgia 561 (25)
Wheezing 269 (12)
Nasal congestion 831 (37)
Headache 314 (14)
Gastrointestinal symptoms 44 (2)
Associated conditions
Pregnancy 22 (1)
Diabetes 112 (5)
Asthma 67 (3)
Table 3
Details of inﬂuenza A (H1N1) 2009 during 2009–2013 [n (%)].
Variables Inﬂuenza A (H1N1)2009 cases P-value
Positives Negatives Total
0–4 yrs 22 (7) 316 (93) 338 <0.001a
5–19 yrs 65 (16) 353 (84) 418
20–49 yrs 166 (14) 1010 (86) 1176
50–64 yrs 30 (13) 204 (87) 234
65 yrs 4 (5) 77 (95) 81
Male 135 (12) 969 (88) 1104 0.44
Female 152 (13) 991 (87) 1143
Admitted: No 147 (11) 1 167 (89) 1314 0.007a
Yes 140 (15) 793 (85) 933
a Statistical signiﬁcance.
Table 4
Details of inﬂuenza A (H3N2) during 2009–2013 [n (%)].
Variables Inﬂuenza A (H3N2) cases P-value
Positives Negatives Total
0–4 yrs 9 (3) 329 (97) 338 0.070
5–19 yrs 9 (2) 409 (98) 418
20–49 yrs 58 (5) 1118 (95) 1176
50–64 yrs 12 (5) 222 (95) 234
65 yrs 4 (5) 77 (95) 81
Male 48 (4) 1056 (96) 1104 0.550
Female 44 (4) 1099 (96) 1143
Admitted: No 53 (4) 1261 (96) 1314 0.862
Yes 39 (4) 894 (96) 933
Figure 2. SARI surveillance ﬂowchart.
OPD-outpatient department, ARI-acute respiratory infections, NCDC-
National center for disease control, SSO-state surveillance ofﬁcer, SARI-
severe acute respiratory infections.
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dyspnea (Table 2).
3.2. Virological surveillance
During 2009–2013 inﬂuenza season, 379 (17%) patients
tested positive for inﬂuenza A viruses using real-time real-time
polymerase chain reaction. Among them, 287 (76%) and 92
(24%) tested positive for inﬂuenza A (H1N1) 2009 and inﬂuenza
A (H3N2) respectively (Table 3 and 4). Starting from November
2011, a subset of 557 samples were also tested for inﬂuenza BTable 1
Details of inﬂuenza-like illness activity during 2009–2013 [n (%)].
Variables 2009
(n = 523)
2010
(n = 429)
2011
(n = 153)
2012
(n = 717)
2013
(n = 425)
0–4 yrs 20 (4) 4 (1) 28 (18) 136 (19) 150 (35)
5–19 yrs 111 (21) 67 (16) 25 (16) 133 (18) 82 (19)
20–49 yrs 322 (62) 287 (67) 72 (47) 350 (49) 145 (34)
50–64 yrs 48 (9) 57 (13) 17 (11) 72 (10) 40 (10)
65 yrs 22 (4) 14 (3) 11 (8) 26 (4) 8 (2)
Male 295 (56) 215 (50) 70 (46) 332 (46) 192 (45)
Female 228 (44) 214 (50) 83 (54) 385 (54) 233 (55)
Outpatients 263 (50) 198 (46) 70 (46) 450 (63) 333 (78)
Admitted
patients
260 (50) 231 (54) 83 (54) 267 (37) 92 (22)with 24 (4.3%) testing positive; 13 were children and 11 were
adults; 16 male, 8 female. No signiﬁcant difference in the
inﬂuenza positivity was observed based on the area of residence
of ILI patients (Table 5).Table 5
Geographic details of the total number of ILI patients and inﬂuenza
positives during 2009–2013 [n (%)].
Area Inﬂuenza A (H1N1)
2009 positives
Inﬂuenza A
(H3N2) positives
Total number
of patients
Tamil Nadu 93 (12) 32 (4) 798
Puducherry 165 (13) 60 (5) 1277
Karaikkal 27 (17) 0 159
Others 2 (15) 0 13
Figure 4. Seasonal distribution of ILI and inﬂuenza during 2009–2013.
Primary axis-Mean maximum temperature (C), mean minimum tempera-
ture (C), number of H1N1 cases (black column), number of H3N2 cases
(white column); Secondary axis-Total number of ILI visits, total rainfall
(mm).
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adults (79%). As expected, young and middle aged patients (20–
49 years) were affected more by this pandemic strain (58%)
followed by patients in 5–19 years age group (23%). Similarly,
inﬂuenza A (H3N2) positivity was higher in adults (87%)
particularly in 20–49 year age group (63%). No difference was
observed in inﬂuenza infections among outpatients and in-
patients. Both male and female patients were almost equally
affected by inﬂuenza. Among the total inﬂuenza A (H1N1) 2009
positives, 9% reported history of travel in the last 8 d before the
onset of symptoms and 18% had exposure to suspected/
conﬁrmed cases with respiratory symptoms.
3.3. Clinical complications and mortality
In the study duration of 5 years (2009–2013), 933 (42%)
patients were hospitalized due to severe respiratory complica-
tions. Majority of the hospitalized patients were in the age group
of 20–49 years (59%, 554/933); the most predominant reason for
hospitalization was acute respiratory distress syndrome. Of the
total hospitalized, 184 (20%) patients tested positive for inﬂu-
enza A viruses; 140 (15%), 39 (4%) and 5 (0.5%) tested positive
for swine inﬂuenza A (H1N1) 2009, seasonal inﬂuenza A
(H3N2) and inﬂuenza B viruses respectively.
In total, 33 patients died during the study period due to severe
respiratory complications of whom 23 had inﬂuenza A [22-
inﬂuenza A (H1N1) 2009, 1-inﬂuenza A (H3N2)]; All the 22
patients who died of severe respiratory complications due to
inﬂuenza A (H1N1) 2009 infection were adults (Figure 3), 13
were female, 9 were male; 2 had diabetes mellitus and none were
asthmatic or pregnant. Interestingly 13 patients had already
received Oseltamivir before sample collection; however time
and day of start of treatment were not recorded for all the cases.
3.4. Seasonal distribution of ILI and inﬂuenza
Inﬂuenza infection was at the peak during the pandemic
outbreak of 2009 (August–December), where 40% (116/287) of
the swine inﬂuenza A (H1N1) 2009 and 41% (38/92) of the
seasonal inﬂuenza A (H3N2) cases were recorded (Figure 4). In
2010, there was a sharp peak of swine inﬂuenza positives in
September and October (62 cases) after which in 2011, it came
to a low with only 4 cases (1%). Again in 2012, there was
increased swine inﬂuenza activity, where 35% (100/287) of the
inﬂuenza A (H1N1) 2009 were observed. However, unlike in
2009 and 2010, where swine inﬂuenza cases peaked in the 2nd
half of the year (August–December), 70% of the cases in 2012Figure 3. Number of inﬂuenza A (H1N1) 2009-associated deaths by year
and age distribution.were observed in 1st half (March–June) of the year (70/100).
The number of seasonal inﬂuenza cases was less than swine
inﬂuenza throughout the study period (1:3) and 2012 had no
positive cases.
3.5. Sequencing
Sequencing of HA and NA gene was done for representative
swine inﬂuenza A (H1N1) 2009 isolates of each year and all the
sequences (KM654292, KM654293, KM654294 and
KM654295) showed 98%–99% homology with the clade I
reference strain Inﬂuenza A/California/07/2009 and there were
no signiﬁcant mutations seen in these sequences.
4. Discussion
During this study, the number of ILI patients varied from
year to year, more ILI cases were observed in 2009, in response
to the alert created by the spread of inﬂuenza A (H1N1) 2009
pandemic throughout the world, as also in 2012, which again
saw a sharp rise in the number of inﬂuenza A (H1N1) 2009
cases.
In our study, the contribution of inﬂuenza to ILI was
approximately 21% which corroborates several reports from all
over the world [5–7]. The predominant type of inﬂuenza A virus
in this study was pandemic inﬂuenza A (H1N1) 2009. This
ﬁnding is consistent with other reports from Delhi and
Lucknow [8,9]. However, contradictory reports of increased
seasonal inﬂuenza A (H3N2) have been reported from China
during the same period [10].
Although the ﬁrst case of pandemic inﬂuenza A (H1N1)
2009 in India was reported from Hyderabad in May 2009, the
ﬁrst case in this region was reported after 3 months in August
2009, when a 5-year-old female from Cuddalore district, Tamil
Nadu tested positive by real-time PCR. The total positivity of
inﬂuenza A (H1N1) 2009 was 12.7%, which is comparatively
less than other parts of India like New Delhi (18%), Maharashtra
(27%), Kerala (23%) and higher than in eastern India (7%) and
England (7%) [11–15]. There was increased number of inﬂuenza
A (H1N1) 2009 cases in 2012, two years after the pandemic
outbreak. This ﬁnding is supported by a statement released by
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circulate as seasonal viruses for few more years, causing
occasional outbreaks [16].
Mortality rate of inﬂuenza A (H1N1) 2009 infection was 1%
and similar scenario was observed in state of Kolkata (1%) and it
is lower than reports from Gujarat (19%), Brazil (11%) [17–19].
Low mortality rate could be because of timely admission,
immediate initiation of oseltamivir prophylaxis in the
suspected cases and surplus availability of oseltamivir due to
the awareness created by the pandemic. Although the
mortality rate was low, it is of concern that 13 of 22 patients
who died of pandemic inﬂuenza infection had received
oseltamivir prior to sample collection; hence studies are
ongoing to detect mutations involved in resistance, if any.
Oseltamivir is the oral anti-viral drug for the treatment of
inﬂuenza A and B viruses and sporadic cases of oseltamivir
resistant swine inﬂuenza A (2009) have been reported since
2009. A speciﬁc mutation causing a histidine to tyrosine sub-
stitution (H275Y) is known to confer oseltamivir resistance in
these swine inﬂuenza viruses. In India, Potdar et al., reported a
single isolate of pandemic inﬂuenza A (H1N1) resistant to
oseltamivir in 2013 with H275Y mutation [20]. Although the
sequencing analysis of the representative inﬂuenza isolates in
this study showed no signiﬁcant mutations in the HA and NA
genes, continuous monitoring of genetic analysis for
oseltamivir resistance is important as it is the most widely
used antiviral drug against inﬂuenza.
Worldwide, it has been reported pandemic inﬂuenza A
(H1N1) 2009 infected young adults more than any other group
of patients [21]. Similarly, in this study maximum number of
pandemic ﬂu positivity was observed in young adults. There
are a few studies from western countries where more number
of children were affected by pandemic inﬂuenza than adults
[22,23], however in those studies the deﬁnition of children used
was 18 years unlike in the present study here 13 years is
used as cut off. In 2011–2012, there were reports of shift in
the age distribution of pandemic inﬂuenza cases, and more
elderly individuals aged >60 years were affected [24], but such
association was not observed in our study, and consistently it
was individuals aged 20–49 years who were affected more due
to the pandemic inﬂuenza infection. Although it is proposed
that children and the elderly are prone to seasonal inﬂuenza
infection [25], no such association was observed between the
ages and as such the number of cases of seasonal inﬂuenza
were low throughout the study period in this region. The
seasonal inﬂuenza A (H3N2) positivity was only 4%
compared to a study from Pune, India where equal proportion
of seasonal and pandemic inﬂuenza was reported [26]. This
observation cannot be explained unless a detailed analysis of
climatic factors like humidity, pressure and healthy seeking
behavior of patients for mild upper respiratory infections is
studied.
Each year inﬂuenza-like illness activity was found to be
consistently high during the months of lower mean temperature
and maximum rainfall in this region (September–November),
except in 2012 when the ﬁrst phase of inﬂuenza positives came
in peak summer season (March–May) followed by the second
phase in rainy months. Also, it was observed that the number of
patient visits was higher during the periods of increased rainfall
in this region. The pattern of inﬂuenza observed here showed a
unimodal peak during the monsoon season and this pattern is
reported in other studies from India and other tropical state likeBrazil [9,27]. The reason may be due to crowding in houses and
increased risk of transmission of inﬂuenza.
To the best of our knowledge, the present study is the ﬁrst to
report prevalence and seasonality of inﬂuenza viruses, in and
around Union territory of Puducherry from 2009 to 2013.
Inﬂuenza A viruses are still considered to be a threat to human
society due to their frequent mutations, hence continuous
monitoring of antigenic variants of inﬂuenza isolates and trend
of association with seasonal factors is necessary to help in future
pandemic preparedness.
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